Industry
Philips (China) Investment CO., LTD
Total Trials
4
Recruiting
0
Active
0
Completed
1
Success Rate
25.0%-62% vs avg
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 100/100
Failure Rate
75.0%
3 terminated/withdrawn out of 4 trials
Success Rate
25.0%
-61.5% vs industry average
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed trials have results
Key Signals
Enrollment Performance
Analytics
N/A
4(100.0%)
4Total
N/A(4)
Activity Timeline
Global Presence
Loading network data...
Clinical Trials (4)
Showing 4 of 4 trials
NCT04519489Not ApplicableTerminated
The Efficacy of PAP Therapy on Reducing AF Recurrence in Patients With Morbidity of OSA
Role: lead
NCT06095479Not ApplicableCompleted
Ultrasound Liver Fat Quantification on Pediatric Patients
Role: lead
NCT05017233Not ApplicableTerminated
Spectral CT Clinical Trial Protocol
Role: lead
NCT05361356Not ApplicableTerminated
Spectral CT Clinical Trial
Role: lead
All 4 trials loaded